Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
SB Krintel & CT Nielsen. (2019) Rapidly progressive endomyocardial fibrosis and heart failure in a 17-year-old female with limited cutaneous systemic sclerosis. Scandinavian Journal of Rheumatology 48:4, pages 336-337.
Read now
Read now
G De Luca, C Campochiaro, S Franchini, S Sartorelli, C Candela, G Peretto, S Sala & L Dagna. (2019) Unexpected acute lymphocytic virus-negative myocarditis in a patient with limited cutaneous systemic sclerosis: a case report. Scandinavian Journal of Rheumatology 48:2, pages 166-167.
Read now
Read now
Francesco Zulian, Marta Balzarin & Carolina Birolo. (2017) Recent advances in the management of juvenile systemic sclerosis. Expert Review of Clinical Immunology 13:4, pages 361-369.
Read now
Read now
G De Luca, S Bosello, AM Leone, F Gabrielli, G Pelargonio, F Inzani, F Crea & G Ferraccioli. (2017) Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst. Scandinavian Journal of Rheumatology 46:1, pages 78-80.
Read now
Read now
Articles from other publishers (24)
Giacomo De Luca, Marco Matucci-Cerinic & Sophie I. Mavrogeni. (2024) Diagnosis and management of primary heart involvement in systemic sclerosis. Current Opinion in Rheumatology 36:1, pages 76-93.
Crossref
Crossref
Anna Nowakowska-Płaza, Jakub Wroński, Joanna Werońska-Tatara, Agnieszka Foryś, Alicja Kraska & Małgorzata Wisłowska. (2022) Heart disease in the course of systemic sclerosis – an observational study. Rheumatology 60:5, pages 318-325.
Crossref
Crossref
Arianna Ferlito, Corrado Campochiaro, Alessandro Tomelleri, Lorenzo Dagna & Giacomo De Luca. (2022) Primary heart involvement in systemic sclerosis, from conventional to innovative targeted therapeutic strategies. Journal of Scleroderma and Related Disorders 7:3, pages 179-188.
Crossref
Crossref
Giacomo De Luca, Anna Palmisano, Corrado Campochiaro, Davide Vignale, Giulio Cavalli, Elisa Bruno, Silvia Sartorelli, Arianna Ferlito, Giovanni Peretto, Simone Sala, Marco Matucci-Cerinic, Lorenzo Dagna & Antonio Esposito. (2022) Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation. Rheumatology.
Crossref
Crossref
Giacomo De Luca, Sara Bombace & Lorenzo Monti. (2022) Heart Involvement in Systemic Sclerosis: the Role of Magnetic Resonance Imaging. Clinical Reviews in Allergy & Immunology 64:3, pages 343-357.
Crossref
Crossref
Madelon C Vonk. (2020) Is there still a role for cyclophosphamide in the treatment of systemic sclerosis?. Journal of Scleroderma and Related Disorders 6:2, pages 117-122.
Crossref
Crossref
Burabha Pussadhamma, Thapanee Tipparot, Naruemol Chaosuwannakit, Ajanee Mahakkanukrauh, Siraphop Suwannaroj, Ratanavadee Nanagara & Chingching Foocharoen. (2020) Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot Study. International Journal of Rheumatology 2020, pages 1-10.
Crossref
Crossref
Giacomo De Luca, Corrado Campochiaro, Maria De Santis, Silvia Sartorelli, Giovanni Peretto, Simone Sala, Giovanni Canestrari, Enrico De Lorenzis, Cristina Basso, Stefania Rizzo, Gaetano Thiene, Anna Palmisano, Antonio Esposito, Carlo Selmi, Elisa Gremese, Paolo Della Bella, Lorenzo Dagna & Silvia Laura Bosello. (2020) Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis. Rheumatology 59:9, pages 2523-2533.
Crossref
Crossref
Giacomo De Luca, Corrado Campochiaro, Silvia Sartorelli, Giovanni Peretto & Lorenzo Dagna. (2020) Therapeutic strategies for virus-negative myocarditis: a comprehensive review. European Journal of Internal Medicine 77, pages 9-17.
Crossref
Crossref
Sophie I. Mavrogeni, George Markousis-Mavrogenis, Constantina Aggeli, Dimitris Tousoulis, George D. Kitas, Genovefa Kolovou, Efstathios K. Iliodromitis & Petros P. Sfikakis. (2019) Arrhythmogenic Inflammatory Cardiomyopathy in Autoimmune Rheumatic Diseases: A Challenge for Cardio-Rheumatology. Diagnostics 9:4, pages 217.
Crossref
Crossref
Jelena Blagojevic, Paul Legendre, Marco Matucci-Cerinic & Luc Mouthon. (2019) Is there today a place for corticosteroids in the treatment of scleroderma?. Autoimmunity Reviews 18:12, pages 102403.
Crossref
Crossref
Laura Ross, David Prior, Susanna Proudman, Alessandra Vacca, Murray Baron & Mandana Nikpour. (2019) Defining primary systemic sclerosis heart involvement: A scoping literature review. Seminars in Arthritis and Rheumatism 48:5, pages 874-887.
Crossref
Crossref
Kyle A. Batton, Christopher O. Austin, Katelyn A. Bruno, Charles D. Burger, Brian P. Shapiro & DeLisa Fairweather. (2018) Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease. Biology of Sex Differences 9:1.
Crossref
Crossref
Vasiliki-Kalliopi Bournia, Christos Tountas, Athanase D. Protogerou, Stylianos Panopoulos, Sophie Mavrogeni & Petros P. Sfikakis. (2018) Update on assessment and management of primary cardiac involvement in systemic sclerosis. Journal of Scleroderma and Related Disorders 3:1, pages 53-65.
Crossref
Crossref
Sophie Mavrogeni, Loukia Koutsogeorgopoulou, Georgia Karabela, Efthymios Stavropoulos, Gikas Katsifis, John Raftakis, Sotiris Plastiras, Michel Noutsias, George Markousis-Mavrogenis & Genovefa Kolovou. (2017) Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria. BMC Cardiovascular Disorders 17:1.
Crossref
Crossref
Jacob M. van Laar & Robert W. Simms. 2017. Scleroderma. Scleroderma
567
582
.
Sanjiv J. Shah, Ahmad Mahmood & J. Gerry Coghlan. 2017. Scleroderma. Scleroderma
331
356
.
Giacomo De Luca, Silvia Laura Bosello, Francesca Augusta Gabrielli, Giorgia Berardi, Federico Parisi, Manuela Rucco, Giovanni Canestrari, Francesco Loperfido, Leonarda Galiuto, Filippo Crea & Gianfranco Ferraccioli. (2016) Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome. PLOS ONE 11:4, pages e0153012.
Crossref
Crossref
Maurizio Pieroni, Maria De Santis, Gaetano Zizzo, Silvia Bosello, Costantino Smaldone, Mara Campioni, Giacomo De Luca, Antonella Laria, Agostino Meduri, Fulvio Bellocci, Lorenzo Bonomo, Filippo Crea & Gianfranco Ferraccioli. (2014) Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression. Seminars in Arthritis and Rheumatism 43:4, pages 526-535.
Crossref
Crossref
Robert Dinser, Marc Frerix, Florian M.P. Meier, Karin Klingel & Andreas Rolf. (2013) Endocardial and myocardial involvement in systemic sclerosis – is there a relevant inflammatory component?. Joint Bone Spine 80:3, pages 320-323.
Crossref
Crossref
Jacob M. van Laar. 2012. Scleroderma. Scleroderma
577
589
.
Sanjiv J. Shah & André Kahan. 2012. Scleroderma. Scleroderma
373
393
.
Allison EdgecombeJohn Veinot. (2011) Myocarditis at Post-Mortem Examination: A Forensic Perspective. Academic Forensic Pathology 1:2, pages 216-223.
Crossref
Crossref
Cecilia Chighizola, Voon H Ong & Christopher P Denton. (2011) Cyclophosphamide as disease-modifying therapy for scleroderma: pros and cons. International Journal of Clinical Rheumatology 6:2, pages 219-230.
Crossref
Crossref